[EN] NOVEL P2X7R ANTAGONISTS AND THEIR USE<br/>[FR] NOUVEAUX ANTAGONISTES P2X7R ET LEUR UTILISATION
申请人:AFFECTIS PHARMACEUTICALS AG
公开号:WO2012110190A1
公开(公告)日:2012-08-23
The present application is directed to novel P2X7R antagonists that are N-indol-3-yl-acetamide and N-azaindol-3-yl-acetamide compounds, pharmaceutical compositions comprising the same and their use for the prophylactic or therapeutic treatment of diseases mediated by P2X7R activity.